OTCMKTS:ESALY Eisai (ESALY) Stock Price, News & Analysis $61.51 -1.33 (-2.11%) As of 01/30/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Eisai Stock (OTCMKTS:ESALY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Eisai alerts:Sign Up Key Stats Today's Range$61.00▼$63.2950-Day Range$61.51▼$61.5152-Week Range$36.88▼$73.90Volume331,800 shsAverage Volume60,916 shsMarket Capitalization$17.64 billionP/E Ratio70.70Dividend Yield1.43%Price TargetN/AConsensus RatingN/A Company OverviewEisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.Read More… Receive ESALY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eisai and its competitors with MarketBeat's FREE daily newsletter. Email Address ESALY Stock News HeadlinesEcoNaviSta, Inc. Supports Eisai Co., Ltd.’s Tender OfferMarch 14, 2025 | tipranks.comEisai stock price target cut to JPY5,000 at Citi, retains Buy ratingFebruary 10, 2025 | msn.comTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.June 15, 2025 | Porter & Company (Ad)Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in EuropeOctober 14, 2024 | finance.yahoo.comAlzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatmentSeptember 8, 2024 | cnbc.comThis matcha set helped me break my coffee addiction and I’ve never looked backSeptember 2, 2024 | msn.comEisai Co., Ltd. (ESAIY)July 27, 2024 | finance.yahoo.comBiogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side EventsJuly 26, 2024 | msn.comSee More Headlines ESALY Stock Analysis - Frequently Asked Questions How have ESALY shares performed this year? Eisai's stock was trading at $61.51 at the beginning of the year. Since then, ESALY stock has increased by 0.0% and is now trading at $61.51. View the best growth stocks for 2025 here. How were Eisai's earnings last quarter? Eisai Co., Ltd. (OTCMKTS:ESALY) released its earnings results on Wednesday, August, 4th. The company reported $1.34 EPS for the quarter, beating analysts' consensus estimates of $1.09 by $0.25. The business had revenue of $1.82 billion for the quarter. Eisai had a trailing twelve-month return on equity of 3.86% and a net margin of 4.11%. How do I buy shares of Eisai? Shares of ESALY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/04/2021Today6/15/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryPersonal Services Current SymbolOTCMKTS:ESALY CIK948406 Webwww.eisai.co.jp Phone(133) 817-3700Fax813-3811-6032Employees11,322Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.87 Trailing P/E Ratio70.70 Forward P/E Ratio32.37 P/E Growth2.46Net Income$426.79 million Net Margins4.11% Pretax MarginN/A Return on Equity3.86% Return on Assets2.50% Debt Debt-to-Equity Ratio0.10 Current Ratio2.20 Quick Ratio1.77 Sales & Book Value Annual Sales$6.74 billion Price / Sales2.62 Cash Flow$2.68 per share Price / Cash Flow22.94 Book Value$23.94 per share Price / Book2.57Miscellaneous Outstanding Shares286,770,000Free FloatN/AMarket Cap$17.64 billion OptionableNot Optionable Beta0.31 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (OTCMKTS:ESALY) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eisai Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eisai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.